| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |